BR0114182A - Alcanossulfonatos de fenoxifenila - Google Patents
Alcanossulfonatos de fenoxifenilaInfo
- Publication number
- BR0114182A BR0114182A BR0114182-1A BR0114182A BR0114182A BR 0114182 A BR0114182 A BR 0114182A BR 0114182 A BR0114182 A BR 0114182A BR 0114182 A BR0114182 A BR 0114182A
- Authority
- BR
- Brazil
- Prior art keywords
- phenoxyphenyl
- alkanesulfonates
- preparation
- treatment
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C309/22—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
"ALCANOSSULFONATOS DE FENOXIFENILA". Alcanossulfonatos de fenoxifenila da fórmula (I) (na qual A representa oxigênio ou NH e R^ 3^ representa (C~ 4~-C~ 7~)alquila, que pode ser substituída uma ou mais vezes por flúor ou cloro), processos para a sua preparação, sua aplicação para a preparação de medicamentos para o tratamento e/ou profilaxia de doenças, especialmente para o tratamento de estados dolorosos e doenças neurodegenerativas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10047486A DE10047486A1 (de) | 2000-09-26 | 2000-09-26 | Phenoxyphenyl Alkansulfonate |
PCT/EP2001/010564 WO2002026702A1 (de) | 2000-09-26 | 2001-09-13 | Phenoxyphenyl alkansulfonate |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0114182A true BR0114182A (pt) | 2003-07-29 |
Family
ID=7657564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0114182-1A BR0114182A (pt) | 2000-09-26 | 2001-09-13 | Alcanossulfonatos de fenoxifenila |
Country Status (34)
Country | Link |
---|---|
US (2) | US6756409B2 (pt) |
EP (1) | EP1334086B1 (pt) |
JP (1) | JP2004509946A (pt) |
KR (1) | KR20030039372A (pt) |
CN (1) | CN1476427A (pt) |
AR (1) | AR033575A1 (pt) |
AT (1) | ATE292621T1 (pt) |
AU (2) | AU2054702A (pt) |
BG (1) | BG107634A (pt) |
BR (1) | BR0114182A (pt) |
CA (1) | CA2423171A1 (pt) |
DE (2) | DE10047486A1 (pt) |
EE (1) | EE200300117A (pt) |
ES (1) | ES2240543T3 (pt) |
GT (1) | GT200100193A (pt) |
HN (1) | HN2001000214A (pt) |
HR (1) | HRP20030326A2 (pt) |
HU (1) | HUP0302258A3 (pt) |
IL (1) | IL154968A0 (pt) |
MA (1) | MA26053A1 (pt) |
MX (1) | MXPA03002546A (pt) |
NO (1) | NO20031357L (pt) |
NZ (1) | NZ524886A (pt) |
PE (1) | PE20020408A1 (pt) |
PL (1) | PL361015A1 (pt) |
PT (1) | PT1334086E (pt) |
RU (1) | RU2278853C2 (pt) |
SI (1) | SI1334086T1 (pt) |
SK (1) | SK3442003A3 (pt) |
SV (1) | SV2002000639A (pt) |
UA (1) | UA75369C2 (pt) |
UY (1) | UY26945A1 (pt) |
WO (1) | WO2002026702A1 (pt) |
ZA (1) | ZA200302275B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003061699A1 (fr) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedes pour affections allergiques |
EP2313093A4 (en) | 2008-07-10 | 2012-03-28 | Angion Biomedica Corp | METHOD AND COMPOSITIONS FOR LOW-MOLECULAR MODULATORS OF THE HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY |
US10709497B2 (en) * | 2017-09-22 | 2020-07-14 | Covidien Lp | Electrosurgical tissue sealing device with non-stick coating |
MX2021012250A (es) | 2019-04-11 | 2022-01-18 | Angion Biomedica Corp | Formas solidas de (e)-3-[2-(2-tienil)vinil]-1h-pirazol. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE216642C (pt) * | ||||
BE786644A (fr) * | 1971-07-23 | 1973-01-24 | Hoechst Ag | Derives d'acides phenoxy-4 phenoxy-alcane-carboxyliques leur preparation et les medicaments qui en contiennent |
US3914418A (en) * | 1971-09-02 | 1975-10-21 | Merck & Co Inc | Methods of controlling liver fluke infections |
GB8914660D0 (en) * | 1989-06-26 | 1989-08-16 | Fujisawa Pharmaceutical Co | Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same |
IN186119B (pt) * | 1996-07-25 | 2001-06-23 | Lg Chemical Ltd | |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
NZ337331A (en) * | 1997-02-21 | 2001-05-25 | Bayer Ag | Aryl-sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
US5925654A (en) * | 1997-03-12 | 1999-07-20 | G.D. Searle & Co. | LTA4 , hydrolase inhibitors |
DK1031556T3 (da) * | 1997-10-20 | 2003-02-24 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilinderivater |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
NL1008795C2 (nl) * | 1998-04-02 | 1999-10-05 | Rene Werenfridus Lodewijk Vroo | Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling. |
HN1998000027A (es) * | 1998-08-19 | 1999-06-02 | Bayer Ip Gmbh | Arilsulfonamidas y analagos |
DE19837627A1 (de) * | 1998-08-19 | 2000-02-24 | Bayer Ag | Neue Aminosäureester von Arylsulfonamiden und Analoga |
US6242422B1 (en) * | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
-
2000
- 2000-09-26 DE DE10047486A patent/DE10047486A1/de not_active Withdrawn
-
2001
- 2001-09-13 AU AU2054702A patent/AU2054702A/xx active Pending
- 2001-09-13 EP EP01985700A patent/EP1334086B1/de not_active Expired - Lifetime
- 2001-09-13 HU HU0302258A patent/HUP0302258A3/hu unknown
- 2001-09-13 MX MXPA03002546A patent/MXPA03002546A/es active IP Right Grant
- 2001-09-13 PL PL01361015A patent/PL361015A1/xx not_active Application Discontinuation
- 2001-09-13 CN CNA01819527XA patent/CN1476427A/zh active Pending
- 2001-09-13 UA UA2003043896A patent/UA75369C2/uk unknown
- 2001-09-13 SI SI200130356T patent/SI1334086T1/xx unknown
- 2001-09-13 NZ NZ524886A patent/NZ524886A/en unknown
- 2001-09-13 KR KR10-2003-7003902A patent/KR20030039372A/ko not_active Application Discontinuation
- 2001-09-13 DE DE50105857T patent/DE50105857D1/de not_active Expired - Fee Related
- 2001-09-13 SK SK344-2003A patent/SK3442003A3/sk unknown
- 2001-09-13 JP JP2002531088A patent/JP2004509946A/ja active Pending
- 2001-09-13 PT PT01985700T patent/PT1334086E/pt unknown
- 2001-09-13 RU RU2003112454/04A patent/RU2278853C2/ru not_active IP Right Cessation
- 2001-09-13 AT AT01985700T patent/ATE292621T1/de not_active IP Right Cessation
- 2001-09-13 IL IL15496801A patent/IL154968A0/xx unknown
- 2001-09-13 ES ES01985700T patent/ES2240543T3/es not_active Expired - Lifetime
- 2001-09-13 EE EEP200300117A patent/EE200300117A/xx unknown
- 2001-09-13 WO PCT/EP2001/010564 patent/WO2002026702A1/de active IP Right Grant
- 2001-09-13 CA CA002423171A patent/CA2423171A1/en not_active Abandoned
- 2001-09-13 AU AU2002220547A patent/AU2002220547B2/en not_active Ceased
- 2001-09-13 BR BR0114182-1A patent/BR0114182A/pt not_active IP Right Cessation
- 2001-09-24 AR ARP010104486A patent/AR033575A1/es not_active Application Discontinuation
- 2001-09-24 UY UY26945A patent/UY26945A1/es not_active Application Discontinuation
- 2001-09-24 GT GT200100193A patent/GT200100193A/es unknown
- 2001-09-25 HN HN2001000214A patent/HN2001000214A/es unknown
- 2001-09-25 SV SV2001000639A patent/SV2002000639A/es unknown
- 2001-09-25 PE PE2001000958A patent/PE20020408A1/es not_active Application Discontinuation
- 2001-09-26 US US09/965,708 patent/US6756409B2/en not_active Expired - Fee Related
-
2003
- 2003-03-13 BG BG107634A patent/BG107634A/bg unknown
- 2003-03-24 ZA ZA200302275A patent/ZA200302275B/en unknown
- 2003-03-25 MA MA27075A patent/MA26053A1/fr unknown
- 2003-03-25 NO NO20031357A patent/NO20031357L/no not_active Application Discontinuation
- 2003-04-25 HR HR20030326A patent/HRP20030326A2/hr not_active Application Discontinuation
-
2004
- 2004-05-20 US US10/850,507 patent/US20040214886A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814327A (pt) | Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose | |
BRPI0212455B8 (pt) | composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo | |
BRPI0316532B8 (pt) | composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável | |
BR0111034A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids | |
BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
MA27509A1 (fr) | Formulations a liberation prolongee contenant de la lamotrigine | |
ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
SE0102315D0 (sv) | Compounds | |
BR0108893A (pt) | Composição farmacêutica, composto e processo de preparação de compostos | |
BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
BR0314514A (pt) | Formulações farmacêuticas de modafinil | |
ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
BR0214519A (pt) | Inibidores de fator xa e outras serina proteases envolvidas na cascata da coagulação | |
MA29316B1 (fr) | Derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques | |
BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
PT1259512E (pt) | Compostos de pteridin para o tratamento da psoriase | |
BR9611400A (pt) | "agentes antimicobiano de benzoxazina". | |
BR9913225A (pt) | Novos agentes antibacterianos de isoxazolinona | |
BR0215027A (pt) | Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação | |
BR0315139A (pt) | Agentes antibacterianos de tetraidroquinolina tricìclica | |
BRPI0415753A (pt) | método para tratamento e prevenção da inflamação respiratória com um inibidor de ciclooxigenase-2 em associação com um inibidor de fosfodiesterase 4 e composições que os contêm | |
BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
BRPI0211635B8 (pt) | composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica | |
YU19997A (sh) | Analozi fluorovanog vitamina d3 | |
BR9915729A (pt) | Amidas Èmega de n-arilsulfonil-aminoácido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |